European Generic Markets: How Regulatory Approaches Across the EU Shape Drug Access and Competition
The EU's generic drug approval system uses four pathways with varying timelines and costs. The 2025 Pharma Package reforms aim to speed up access, reduce fragmentation, and increase competition-but national differences still create delays.